MRSA

Researchers find two new antibiotics that offer promise in the fight against drug-resistant bacteria.  

A study on microbe versus microbe battles within the human nose yields a new antibiotic.

Scientists develop a method for synthesizing hundreds of new macrolide antibiotics.

Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.  

Researchers have isolated a new kind of antibiotic from a previously unknown and uncultured bacterial genus.  

Adipocytes under the skin help fight infections by producing an antimicrobial agent.

Second new drug to treat methicillin-resistant Staphylococcus aureus approved under US Food and Drug Administration incentive program. 

Two new drugs—one a single-dose antibiotic—have been developed to treat skin infections, including methicillin-reistant Staphylococcus aureus.

A comparative genomic study shows that researchers can use genetic signatures to predict the toxicity of methicillin-resistant Staphylococcus aureus isolates.

Researchers show that activating an endogenous protease can eliminate bacterial persisters.

Researchers use a protein-lipid complex found in human breast milk to increase the activity of otherwise-ineffective antibiotics against drug-resistant pathogens.

A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.

Sequencing the whole genomes of bacterial pathogens as they spread among hospital patients and health care workers could transform the control of infectious disease.

Wild animals are getting and spreading the deadly antibiotic-resistant bacteria.   

A once rare mobile genetic element could be the cause of a MRSA epidemic in Chinese hospitals.

Just because meat is labeled “antibiotic-free” doesn’t mean it’s antibiotic-resistant superbug-free.

As Germany grapples with an E. coli outbreak, a new strain of MRSA appears in Europe.